Moxonidine And Rasagiline See Triple-Digit Rises In July
Pricewatch UK – July 2020
Moxonidine led the price rises for established generics in the UK in July, with averages for the hypertension treatment more than doubling in some cases. However, among recently-launched products, rasagiline stood out with an average that was more than three times that of the previous month.
You may also be interested in...
Despite the average trade price of ciprofloxacin shooting up in September, no UK price concessions were granted by the DHSC.
Moxonidine topped our table of Biggest Risers for the second month in a row, as UK prices that had doubled in July accelerated even more rapidly in August.
Ahead of the Global Generics & Biosimilars Awards, which are this year being held on Wednesday 25 October at the Hotel Porta Fira in Barcelona, we reveal our final shortlist of entrants across all 14 categories.